Trastuzumab

• Target :

  ADC Antibody|||EGFR

• Related Pathways :

  JAK/STAT signaling|||Antibody-drug Conjugate/ADC Related|||Angiogenesis|||Tyrosine Kinase/Adaptors

• Purity :

  0.995

• Bioactivity :

  Trastuzumab is a humanized monoclonal antibody for patients with invasive breast cancers that overexpress HER2. Trastuzumab has been clinically used to treat HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer.

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  180288-69-1